Related Experiment Video
Updated: Apr 20, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
1.5K
Methotrexate revisited: considerations for subcutaneous administration in RA
1Arizona Arthritis & Rheumatology Associates, P.C., Phoenix, AZ, USA, usjays@cox.net.
Clinical Rheumatology
|December 1, 2014
Summary
Subcutaneous methotrexate (MTX) improves rheumatoid arthritis (RA) treatment by enhancing drug absorption and reducing side effects compared to oral MTX. This optimization may improve patient outcomes and potentially delay the need for expensive biologic therapies.
Area of Science:
- Rheumatology
- Pharmacology
- Immunology
Background:
- Rheumatoid arthritis (RA) causes significant disability and mortality.
- Methotrexate (MTX) is a cornerstone disease-modifying antirheumatic drug (DMARD) for RA.
- Oral MTX has limitations in absorption and tolerability.
Purpose of the Study:
- To evaluate the benefits of subcutaneous (SC) MTX over oral formulations in RA management.
- To highlight SC MTX's potential to improve treatment outcomes and reduce healthcare costs.
Main Methods:
- Comparative analysis of oral versus SC MTX administration in RA patients.
- Assessment of drug absorption, polyglutamization, treatment response, and side effect profiles.
Main Results:
- SC MTX demonstrates improved and consistent drug absorption.
- Enhanced MTX polyglutamization is observed with SC administration.
- SC MTX leads to higher response rates and fewer gastrointestinal side effects than oral MTX.
Conclusions:
- Optimizing RA treatment with SC MTX can enhance patient outcomes.
- SC MTX may offer a more effective and tolerable alternative to oral MTX.
- Improved efficacy and tolerability of SC MTX might delay or eliminate the need for biologics.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
740
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
740
01:29Therapeutic Drug Monitoring: Affecting Factors
403
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
403
01:21Rheumatic Heart Disease III: Medical Management
524
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
524
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
832
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
832
01:22Drug Delivery: Miscellaneous Routes
1.1K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.1K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
692
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
692